MBL Oligomer ELISA Kit 029 on Dynex DS2®
Expanding the assessment of Primary Immunodeficency
BioPorto Diagnostics is pleased to announce that we have developed a protocol for running our market-leading MBL Oligomer ELISA – Kit 029 – on the renowned Dynex DS2® automation system. With this, it is now possible to automate the MBL diagnosis in your laboratory.
If you are interested in moving your MBL diagnostic screening from the time consuming manual procedure to a faster, automated process, please do not hesitate to contact BioPorto Diagnostics.
Request the Application Note and receive further details about this new opportunity, please contact:
Global Sales Manager, Imrana Shahzada, MSc., E-mail email@example.com